Progenics Pharmaceuticals, Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
PGNX Nasdaq 8731 5.37 +0.00

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Latest Headlines for Progenics Pharmaceuticals, Inc

8:36 am Progenics Pharm grants an exclusive license to Bayer (BAYRY) for the development and commercialization of therapeutic antibodies - May 2nd, 2016 6:36 am